Condition: Delirium · Sponsor: Ciusss de L'Est de l'Île de Montréal
The purpose of this study is to determine the feasibility of conducting a randomized controlled trial (RCT) with melatonin for treatment of delirium in critically ill adult patients. From a feasibility perspective, the investigators believe that the proposed design will achieve the minimum enrollment rate necessary to conduct a future RCT on a larger scale.
This description comes directly from the study's public registry record.
Johannie Beaucage-Charron, Pharm.D., M.Sc. · 514 252 3400 · johannie.beaucage-charron.cemtl@ssss.gouv.qc.ca
Always discuss trial participation with your own doctor first.
| Hopital Maisonneuve-Rosemont | Montreal, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05713877